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Introduction
Gastrointestinal (GI) mucosal abnormalities have been
observed within 24 h of admission to ICU and are
thought to represent a ‘stress’ response. While acid-sup-
pressive drugs are frequently administered to ICU
patients, for stress ulcer prophylaxis, there are sparse
data to support its efficacy.
Objectives
To compare the presence of macroscopic mucosal
abnormalities during upper GI endoscopy in mechani-
cally ventilated, critically ill patients randomised to
receive pantoprazole or placebo.
Methods
Ten patients were evaluated (6 M:4 F; age 41.7 ± 4.3 y;
admission APACHE II score 19.4 ± 1.9; pantoprazole
n = 4, and placebo n = 6) from a larger prospective
study, in which 209 mechanically ventilated patients
were randomised to receive IV pantoprazole (40 mg) or
placebo in a double-blind fashion. Patients who received
≥ 5 doses of pantoprazole/placebo (80 patients in total)
were eligible for the endoscopy sub-study. Written and
informed consent was obtained from the patient’s next
of kin. The presence of one or more macroscopic
abnormalities (erythema or oedema, erosions, ulcera-
tions and naso-gastric tube lesions) and GI bleeding
(petechial or sub-mucosal bleeding, haematoma, coffee-
ground material and frank blood) were assessed at endo-
scopy by a single experienced gastroenterologist who
was blinded to the intervention. Data are mean ± SEM
or median (IQR) and were compared using Mann-Whit-
ney U tests or chi-squared tests as appropriate.
Results
Patients had received pantoprazole 8.8 ± 0.3 doses or pla-
cebo 10.7 ± 1.1 doses prior to endoscopy (p = 0.21). One
patient in the pantoprazole group was also receiving cor-
ticosteroids, and another received regular non-steroidal
anti-inflammatory drug therapy. Patient’s haemoglobin
on the day of endoscopy were similar (pantoprazole:
89.8 ± 6.0 vs. placebo: 83.7 ± 3.7g/dL; p = 0.52), one
patient (receiving pantoprazole) had received a blood
transfusion prior to endoscopy. All patients were receiv-
ing enteral nutrition prior to endoscopy. Upper GI muco-
sal abnormalities were observed in a total of 3 patients
treated with pantoprazole (75%) and 4 patients treated
with placebo (66%), without a difference between treat-
ments (p = 0.78). Observed abnormalities included
(i) erythema/oedema/erosions (pantoprazole: 2
patients vs. placebo: 2 patients)
(ii) naso-gastric tube-related lesions (3 vs. 2),
(iii) petechial or sub-mucosal bleeding (0 vs. 2), and
(iv) duodenal ulcer, (0 vs. 1); the latter was not asso-
ciated with bleeding but the patient was switched to
open label pantoprazole.
Conclusions
Upper GI mucosal abnormalities may occur frequently
in mechanically ventilated patients. However, in this
small cohort, the prevalence of mucosal abnormalities
does not appear to be substantially reduced by adminis-
tration of prophylactic pantoprazole.
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